Document is current
Any future updates will be listed below
-
Authors
Kreindler, James L
Watkins, Michael L
Lettis, Sally
Tal-Singer, Ruth
Locantore, Nicholas
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02105948 at ClinicalTrials.govnct02138916 at ClinicalTrials.govDocuments that mention this clinical trial
Effect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPD
https://doi.org/10.1136/bmjresp-2016-000151
nct00358358 at ClinicalTrials.govDocuments that mention this clinical trial
Effect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPD
https://doi.org/10.1136/bmjresp-2016-000151
nct00292552 at ClinicalTrials.govDocuments that mention this clinical trial
Effect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPD
https://doi.org/10.1136/bmjresp-2016-000151
nct00358358 at ClinicalTrials.govDocuments that mention this clinical trial
Relative contributions of family history and a polygenic risk score on COPD and related outcomes: COPDGene and ECLIPSE studies
https://doi.org/10.1136/bmjresp-2020-000755
Prognostic score for predicting respiratory admissions among patients with chronic obstructive pulmonary disease in primary care: development and validation in population cohorts (Birmingham Lung Improvement Studies (BLISS))
https://doi.org/10.1136/bmj-2025-084521
Controversies in treatment of chronic obstructive pulmonary disease
https://doi.org/10.1016/s0140-6736(11)61295-6
Effect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPD
https://doi.org/10.1136/bmjresp-2016-000151
Respiratory exacerbations are associated with muscle loss in current and former smokers
https://doi.org/10.1136/thoraxjnl-2020-215999
Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts
https://doi.org/10.1136/thoraxjnl-2016-209846
Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA
https://doi.org/10.1136/bmjresp-2022-001601
nct00292552 at ClinicalTrials.govDocuments that mention this clinical trial
Effect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPD
https://doi.org/10.1136/bmjresp-2016-000151
Documents that mention this clinical trial
Relative contributions of family history and a polygenic risk score on COPD and related outcomes: COPDGene and ECLIPSE studies
https://doi.org/10.1136/bmjresp-2020-000755
Prognostic score for predicting respiratory admissions among patients with chronic obstructive pulmonary disease in primary care: development and validation in population cohorts (Birmingham Lung Improvement Studies (BLISS))
https://doi.org/10.1136/bmj-2025-084521
Controversies in treatment of chronic obstructive pulmonary disease
https://doi.org/10.1016/s0140-6736(11)61295-6
Effect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPD
https://doi.org/10.1136/bmjresp-2016-000151
Respiratory exacerbations are associated with muscle loss in current and former smokers
https://doi.org/10.1136/thoraxjnl-2020-215999
Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts
https://doi.org/10.1136/thoraxjnl-2016-209846
Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA
https://doi.org/10.1136/bmjresp-2022-001601
